Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
ENSCW ENSYSCE BIOSCIENCES INC C/WTS 30/06/2026 (TO PUR COM)
- 0.023
- 0.0000.00%
15min DelayClose Feb 13 12:55 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.023Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.04552wk High0.00P/B0Float Cap0.00352wk Low--Dividend TTM0Shs Float0.045Historical High--Div YieldTTM0.00%Amplitude0.003Historical Low--Avg Price1Lot Size
About ENSYSCE BIOSCIENCES INC C/WTS 30/06/2026 (TO PUR COM) Company
Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company was founded in April 2003 and is headquartered in La Jolla, CA.
Company Profile
SymbolENSCW
Company NameENSYSCE BIOSCIENCES INC C/WTS 30/06/2026 (TO PUR COM)
Listing DateDec 29, 2017
Founded2003
CEODr. D. Lynn Kirkpatrick, PhD
MarketPink Market
Employees9
Fiscal Year Ends12-31
Address7946 Ivanhoe Avenue,Suite 201
CityLa Jolla
ProvinceCalifornia
CountryUnited States of America
Zip Code92037
Phone1-858-263-4196
Websitehttp://www.ensysce.com
Company Executives
- Name
- Position
- Salary
- Dr. D. Lynn Kirkpatrick, PhD
- President, Chief Executive Officer and Director
- 508.58K
- Dr. William K. Schmidt, PhD
- Chief Medical Officer
- --
- Geoffrey Birkett
- Chief Commercial Officer
- 392.35K
- Dr. Jeffrey Millard, PhD
- Chief Operating Officer
- --
- David Humphrey, C.P.A.
- Chief Financial Officer, Principal Accounting Officer, Secretary and Treasurer
- 441.95K
- Linda Pestano, PhD
- Chief Development Officer
- --
- Dr. Bob G. Gower, PhD
- Chairman of the Board
- 47.60K
- Steve R. Martin
- Independent Director
- 32.92K
- William Chang
- Independent Director
- 30.10K
- Lee Rauch
- Independent Director
- 29.17K
- Andrew Benton, J.D.
- Independent Director
- 30.10K
- Dr. Curtis Rosebraugh, M.D.
- Independent Director
- 25.42K
- Dr. Adam S. Levin, M.D.
- Independent Director
- 27.92K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.